Ken Griffin Sharps Technology Inc. Call Options Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STSS
# of Institutions
12Shares Held
797KCall Options Held
0Put Options Held
0-
Garden State Investment Advisory Services LLC Red Bank, NJ173KShares$599,9940.01% of portfolio
-
Essential Planning, Llc. Portsmouth, NH163KShares$565,0020.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny137KShares$474,9210.0% of portfolio
-
Org Partners LLC Roanoke, IN100KShares$347,1590.0% of portfolio
-
Alpha Core Capital LLC La Jolla, CA88.6KShares$307,3510.0% of portfolio
About Sharps Technology Inc.
- Ticker STSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 9,207,420
- Market Cap $31.9M
- Description
- Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in...